MicroRNA-155 promotes the proliferation of prostate cancer cells by targeting annexin 7

Molecular Medicine Reports

Volumn 11, Issue 1, 2015, Pages 533-538

  Cai, Zhi Kang ^a   Chen, Qi ^a   Chen, Yan Bo ^a   Gu, Meng ^a   Zheng, Da Chao ^a   Zhou, Juan ^a   Wang, Zhong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Annexin 7; Cell proliferation; MiR 155; Prostate cancer

Indexed keywords

ANNEXIN; ANNEXIN 7; MICRORNA 155; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MICRORNA; MIRN155 MICRORNA, HUMAN; SYNEXIN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BINDING SITE; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LUCIFERASE ASSAY; MALE; MTT ASSAY; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENETICS; PROSTATE TUMOR; RNA INTERFERENCE; TUMOR CELL LINE; 22RV1 CELL LINE; CANCER CELL; CANCER TISSUE; DU145 CELL LINE; ENZYME ACTIVITY; HUMAN CELL; IN VITRO STUDY; LNCAP CELL LINE; PC 3 CELL LINE; POLYMERASE CHAIN REACTION; RNA EXTRACTION;

3' UNTRANSLATED REGIONS; ANNEXIN A7; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; PROSTATIC NEOPLASMS; RNA INTERFERENCE;

EID: 84916204195     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2744     Document Type: Article

References (25)

1. Dunn MW and Kazer MW: Prostate cancer overview. Semin Oncol Nurs 27: 241-250, 2011.
2. Ha HK, Lee W, Park HJ, et al: Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer. Mol Med Rep 4: 419-424, 2011.
3. Gosselaar C, Roobol MJ, Roemeling S, van der Kwast TH, and Schröder FH: Screening for prostate cancer at low PSA range: the impact of digital rectal examination on tumor incidence and tumor characteristics. Prostate 67: 154-161, 2007.
4. Katahira K, Takahara T, Kwee TC, et al: Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation. Eur Radiol 21: 188-196, 2011.
5. Stewart GD, Gray K, Pennington CJ, et al: Analysis of hypoxia-associated gene expression in prostate cancer: lysyl oxidase and glucose transporter-1 expression correlate with Gleason score. Oncol Rep 20: 1561-1567, 2008.
6. Arora R, Koch MO, Eble JN, et al: Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer 100: 2362-2366, 2004.
7. Jiang YW and Chen LA: microRNAs as tumor inhibitors, oncogenes, biomarkers for drug effcacy and outcome predictors in lung cancer (review). Mol Med Rep 5: 890-894, 2012.
8. Fang YX and Gao WQ: Roles of microRNAs during prostatic tumorigenesis and tumor progression. Oncogene 2013.
9. Hamamoto J, Soejima K, Yoda S, et al: Identifcation of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma. Mol Med Rep 8: 456-462, 2013.
10. Nazarov PV, Reinsbach SE, Muller A, et al: Interplay of microRNAs, transcription factors and target genes: linking dynamic expression changes to function. Nucleic Acids Res 41: 2817-2831, 2013.
11. Marcucci G, Maharry KS, Metzeler KH, et al: Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients. J Clin Oncol 31: 2086-2093, 2013.
12. Yang M, Shen H, Qiu C, et al: High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. Eur J Cancer 49: 604-615, 2013.
13. Huang X, Taeb S, Jahangiri S, et al: MiRNA-95 mediates radio-resistance in tumors by targeting the sphingolipid phosphatase SGPP1. Cancer Res 2013.
14. Huang X and Jia Z: Construction of HCC-targeting artifcial miRNAs using natural miRNA precursors. Exp Ther Med 6: 209-215, 2013.
15. Shi XB, Xue L, Ma AH, et al: MiR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes. Prostate 71: 538-549, 2011.
16. Zhang CM, Zhao J and Deng HY: MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1. J Biomed Sci 20: 79, 2013.
17. Powell-Coffman JA and Coffman CR: Apoptosis: Lack of oxygen aids cell survival. Nature 465: 554-555, 2010.
18. Li T, Kon N, Jiang L, et al: Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 149: 1269-1283, 2012.
19. Petrocca F, Visone R, Onelli MR, et al: E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13: 272-286, 2008.
20. Higgs G and Slack F: The multiple roles of microRNA-155 in Oncogenesis. J Clin Bioinforma 3: 17, 2013.
21. Streicher WW, Lopez MM and Makhatadze GI: Annexin I and annexin II N-terminal peptides binding to S100 protein family members: specificity and thermodynamic characterization. Biochemistry 48: 2788-2798, 2009.
22. Lokman NA, Ween MP, Oehler MK and Ricciardelli C: The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron 4: 199-208, 2011.
23. Paweletz CP, Ornstein DK, Roth MJ, et al: Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res 60: 6293-6297, 2000.
24. Jin Y, Wang S, Chen W, et al: Annexin A7 suppresses lymph node metastasis of hepatocarcinoma cells in a mouse model. BMC Cancer 13: 522, 2013.
25. Srivastava M, Bubendorf L, Srikantan V, et al: ANX7, a candidate tumor suppressor gene for prostate cancer. Proc Natl Acad Sci USA 98: 4575-4580, 2001.